Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Article

    Evaluation of Mimusops elengi L. flowers using pharmacognostic approach

    wadmin2By wadmin2December 12, 2014Updated:August 10, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Sunita Shailajan and Deepti Gurjar
    Herbal Research Lab, Ramnarain Ruia College, Matunga (E), Mumbai 400019, India.

    Pharmacognosy Communications,2015,5,1,83-92.
    DOI:10.5530/pc.2015.1.9
    Published:12 2014
    Type:Research Article

    ABSTRACT

    Background: Mimusops elengi L. (Sapotaceae, Bakul) is an integral part of many Ayurvedic formulations. Flowers of M. elengi have been traditionally used for their therapeutic activities like antiulcer, wound healing, antioxidant, etc. Flowers are also reported as a brain tonic, expectorant and have been used for the treatment of asthma. Materials and methods: The present study was aimed to evaluate the pharmacognostic profile of M. elengi flowers as per the standard methods which included evaluation of proximate characters, heavy metals and chromatographic characterization. The study also included evaluation of safety profile of the plant in Albino Wistar rats as per the OECD test guidelines no. 420. Results: Various analytical values for M. elengi flowers were established. M. elengi flowers were found to be a source of terpenoids and phenolics as per the results of chromatographic characterization. M. elengi flowers were also found safe up to an oral dose of 2.0 g/kg body weight in rats. Conclusion: The pharmacognostic profile for M. elengi flowers obtained as a finding of this research work will contribute in their identification and standardization.

    Keywords: Mimusops elengi L. flowers, physicochemical evaluation, phytochemical evaluation, safety evaluation.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up